BYAKANGELICIN (b)
BYAKANGELICINa main furanocoumarin constituent isolated and characterized as an aldose reductase inhibitorand is effective for the treatment of sugar cataracts and diabetic neuropathy and hence might be useful as a lead compound for the development of new type drugs for clinical use.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
334.32
Molecular Formula
C17H18O7
Notes
Research use only, not for human use.
Receptor
Aldose reductase
CAS Number
482-25-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
